![Quiver Logo](/static/img/logo-icon.png)
![AVDL logo](https://quiver-logos.s3.us-east-2.amazonaws.com/avdl.png)
Avadel Pharmaceuticals plc Ordinary Share
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view AVDL Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of AVDL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by AVDL's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to AVDL
Recent picks made for AVDL stock on CNBC
ETFs with the largest estimated holdings in AVDL
Flights by private jets registered to AVDL
![Quiver Logo](/static/img/logo-icon.png)